The introduction of Ozempic and Wegovy in Kenya is drawing attention to the country’s growing cardio-metabolic health burden, as healthcare experts call for a more comprehensive approach to the prevention and management of type 2 diabetes, obesity and related conditions. Novo Nordisk hosted a scientific launch event in Nairobi on Saturday to introduce Ozempic for the management of […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.